GL1X · GenesisL1 explorer

Research workbench

Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 45).

Analyse Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4CYQ
Type
protein
Length
411 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycylpeptide N-tetradecanoyltransferase
EC
2.3.1.97
UniProt
Q4Q5S8
Ligands
YAU, MYA, MG
Pockets
2 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycylpeptide N-tetradecanoyltransferase (EC 2.3.1.97)protein41133% helix, 28% strandQ4Q5S8

Ligands and binding sites

  • YAU · N-{2-chloro-5-[(3S,4R)-1-[(3R)-4-(4-chlorophenyl)-3-hydroxybutanoyl]-4-(hydroxymethyl)pyrrolidin-3-yl]phenyl}-2-(4-fluorophenyl)acetamide · ligand · chains A
  • MYA · Tetradecanoyl-coa · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110250.810.8279MG, YAU, MYA
21350.430.7624empty

Compared structures

  • 4CYQ · Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 45). · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.